Founded in 2010, LNC Therapeutics is a French biotech company specialized in research & development of gut microbiome-based drugs. LNC Therapeutics’ goal is to develop new drug candidates to treat obesity and other metabolic diseases and to expand research and development to other indications for which no treatments exist yet. Backed by leading venture capital investors such as Seventure Partners, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs.